Urologia

Surgical Management of Kidney and Ureteral Stones: AUA Guideline (2026). Part II: Evaluation and Treatment of Patients With Kidney and/or Ureteral Stones.

The Journal of urology. 2026 Feb; 215(Feb):124-131. doi: 10.1097/JU.0000000000004843. pii: .

Surgical Management of Kidney and Ureteral Stones: AUA Guideline (2026). Part III: Treatment of Patients With Kidney and/or Ureteral Stones and Future Directions.

The Journal of urology. 2026 Feb; 215(Feb):132-141. doi: 10.1097/JU.0000000000004844. pii: .

Infection Prophylaxis in Urological Diagnostic and Surgical Procedures - A narrative review and recommendations.

International braz j urol : official journal of the Brazilian Society of Urology. 2025 ; 51():doi: 10.1590/S1677-5538.IBJU.2025.0333. pii: e20250333.

An update on mechanisms and treatment options for priapism.

Nature reviews. Urology. 2025 Dec; 22(Dec):826-845. doi: 10.1038/s41585-025-01069-9. pii: .

An update on the pharmacotherapy of penile cancer.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 2025 Oct; 10781552251383790. doi: 10.1177/10781552251383790. pii: .

Testicular germ cell tumors and molecular biomarkers.

Current opinion in urology. 2026 Mar; 36(Mar):205-211. doi: 10.1097/MOU.0000000000001353. pii: .

A rapid evidence assessment for extracorporeal magnetic stimulation to treat urinary incontinence in men.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2026 Feb; 20(Feb):63-70. doi: 10.5489/cuaj.9320. pii: .

Prostate cancer.

Lancet (London, England). 2026 Feb; 407(Feb):622-636. doi: 10.1016/S0140-6736(25)02221-4. pii: S0140-6736(25)02221-4.

Lectin based immunochromatographic assay for detection of kidney infections.

Diagnostic microbiology and infectious disease. 2026 Jan; 114(Jan):117076. doi: 10.1016/j.diagmicrobio.2025.117076. pii: S0732-8893(25)00399-2.

Recent advances in urologic surgical pathology and molecular biomarker testing.

Current opinion in urology. 2026 Mar; 36(Mar):135-137. doi: 10.1097/MOU.0000000000001368. pii: .

Histologic subtypes of urothelial carcinoma: an update.

Current opinion in urology. 2026 Mar; 36(Mar):138-146. doi: 10.1097/MOU.0000000000001358. pii: .

A Review of Prostatitis.

JAMA. 2026 Feb; 335(Feb):459. doi: 10.1001/jama.2025.21097. pii: .

Modern integrative prostate cancer diagnostics.

Current opinion in urology. 2025 Dec; doi: 10.1097/MOU.0000000000001361. pii: .

Autocatalytic Signal Amplification via Orthogonal Recognition of Dual Proteins on the Surface of Serum Extracellular Vesicles for Precise Diagnosis of Prostate Cancer.

ACS sensors. 2026 Jan; 11(Jan):181-189. doi: 10.1021/acssensors.5c02768. pii: .

Safety and efficacy of the Chinese surgical robotic system (EDGE MP1000 & MP2000) for robot-assisted radical prostatectomy: results from a single high-volume center.

Journal of robotic surgery. 2026 Jan; 20(Jan):202. doi: 10.1007/s11701-025-02999-7. pii: .

What Is Prostatitis?

JAMA. 2026 Jan; doi: 10.1001/jama.2025.20559. pii: .

Sentinel lymph node staging in urological cancer surgery: advances in imaging, intra-operative detection and translational research.

BJU international. 2025 Dec; 136(Dec):979-989. doi: 10.1111/bju.16848. pii: .

CAUTIon - not all UTIs are the same.

Nature reviews. Urology. 2025 Dec; 22(Dec):799-814. doi: 10.1038/s41585-025-01065-z. pii: .

Perioperative Antimicrobial Strategies in Inflatable Penile Prosthesis Surgery: Associations Between Antifungals, Oral Antibiotics, and Intravenous Antibiotic Duration, and Infection Outcomes.

The Journal of urology. 2025 Dec; 214(Dec):642-653. doi: 10.1097/JU.0000000000004716. pii: .

The Blind Spot of Prostate-Specific Membrane Antigen Positron Emission Tomography Staging? Intraductal Carcinoma of the Prostate Is Overrepresented in Patients With No Uptake Pattern on Prostate-Specific Membrane Antigen Positron Emission Tomography and High-Grade Prostate Cancer.

The Journal of urology. 2025 Dec; 214(Dec):582-590. doi: 10.1097/JU.0000000000004734. pii: .

Toxicities of novel androgen receptor pathway inhibitor targeted therapies in advanced prostate cancer.

Current opinion in urology. 2025 Nov; 35(Nov):696-706. doi: 10.1097/MOU.0000000000001341. pii: .

Novel intravesical delivery systems for nonmuscle invasive bladder cancer.

Current opinion in urology. 2025 Nov; 35(Nov):645-652. doi: 10.1097/MOU.0000000000001326. pii: .

Updates to Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline (2025).

The Journal of urology. 2026 Jan; 215(Jan):3-12. doi: 10.1097/JU.0000000000004723. pii: .

Radiotherapy for penile cancers: 2025 update.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 2025 ; 29():104761. doi: 10.1016/j.canrad.2025.104761. pii: S1278-3218(25)00177-5.

Application of transurethral blue laser vaporization of the prostate in patients aged 80 and above: a single-center clinical analysis of 157 cases.

Lasers in medical science. 2025 Dec; 40(Dec):532. doi: 10.1007/s10103-025-04784-2. pii: .

UroLift, Rezūm, and iTind for Benign Prostatic Hyperplasia.

The Urologic clinics of North America. 2025 Nov; 52(Nov):547-558. doi: 10.1016/j.ucl.2025.07.010. pii: S0094-0143(25)00065-5.

Making Waves: An Update on Aquablation.

The Urologic clinics of North America. 2025 Nov; 52(Nov):535-545. doi: 10.1016/j.ucl.2025.07.009. pii: S0094-0143(25)00064-3.

Balloons in Benign Prostatic Hyperplasia: Will They Float? A Comprehensive Review of Prostatic Balloon Prostatoplasty.

The Urologic clinics of North America. 2025 Nov; 52(Nov):559-566. doi: 10.1016/j.ucl.2025.07.007. pii: S0094-0143(25)00062-X.

Laser Enucleation Therapy for Benign Prostatic Hyperplasia.

The Urologic clinics of North America. 2025 Nov; 52(Nov):523-534. doi: 10.1016/j.ucl.2025.07.004. pii: S0094-0143(25)00059-X.

Artificial Intelligence in Benign Prostatic Hyperplasia.

The Urologic clinics of North America. 2025 Nov; 52(Nov):509-522. doi: 10.1016/j.ucl.2025.07.005. pii: S0094-0143(25)00060-6.

Summary of the clinical practice guideline for the management of urinary stones, third edition.

International journal of urology : official journal of the Japanese Urological Association. 2025 May; 32(May):462-474. doi: 10.1111/iju.70004. pii: .

Consensus position statement on advancing the classification of patients and tests of cure in studies of antibiotic treatment of complicated urinary tract infections.

The Lancet. Infectious diseases. 2025 Oct; 25(Oct):e605-e618. doi: 10.1016/S1473-3099(25)00142-2. pii: S1473-3099(25)00142-2.

Update and summary of the EAU/ESPU paediatric guidelines on urinary tract infection in children.

Journal of pediatric urology. 2025 Jun; doi: 10.1016/j.jpurol.2025.06.016. pii: S1477-5131(25)00321-3.

The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause.

The Journal of urology. 2025 Sep; 214(Sep):242-250. doi: 10.1097/JU.0000000000004589. pii: .

Multiparametric Magnetic Resonance Imaging and Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnosis and Staging: A Guide for Clinicians from the American College of Radiology VI-RADS Steering Committee.

European urology. 2025 Oct; doi: 10.1016/j.eururo.2025.10.010. pii: S0302-2838(25)04769-4.

Male Chronic Pelvic Pain: AUA Guideline: Part I Evaluation and Management Approach.

The Journal of urology. 2025 Aug; 214(Aug):116-126. doi: 10.1097/JU.0000000000004564. pii: .

Male Chronic Pelvic Pain: AUA Guideline: Part II Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.

The Journal of urology. 2025 Aug; 214(Aug):127-137. doi: 10.1097/JU.0000000000004565. pii: .

European Association of Urology-European Society of Paediatric Urology Guidelines on Paediatric Urology: Summary of 2024 Updates. Part II.

European urology. 2025 Aug; 88(Aug):190-203. doi: 10.1016/j.eururo.2025.02.022. pii: S0302-2838(25)00144-7.

European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Hypogonadism, Erectile Dysfunction, Premature Ejaculation, and Peyronie's Disease.

European urology. 2025 Jul; 88(Jul):76-102. doi: 10.1016/j.eururo.2025.04.010. pii: S0302-2838(25)00211-8.

International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1: The Prostate.

The American journal of surgical pathology. 2025 Jun; doi: 10.1097/PAS.0000000000002430. pii: .

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines.

European urology. 2025 May; 87(May):582-600. doi: 10.1016/j.eururo.2025.02.019. pii: S0302-2838(25)00138-1.

Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitors and Subsequent Therapy for Renal Cell Carcinoma.

European urology. 2025 Apr; 87(Apr):491-496. doi: 10.1016/j.eururo.2025.01.014. pii: S0302-2838(25)00026-0.

Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).

European urology. 2025 Feb; 87(Feb):157-216. doi: 10.1016/j.eururo.2024.09.017. pii: S0302-2838(24)02610-1.

Updates to Incontinence After Prostate Treatment: AUA/GURS/SUFU Guideline (2024).

The Journal of urology. 2024 Oct; 212(Oct):531-538. doi: 10.1097/JU.0000000000004088. pii: .

Metabolic Evaluation and Recurrence Prevention for Urinary Stone Patients: An EAU Guidelines Update.

European urology. 2024 Oct; 86(Oct):343-363. doi: 10.1016/j.eururo.2024.05.029. pii: S0302-2838(24)02411-4.

Prostate Cancer, Version 3.2024.

Journal of the National Comprehensive Cancer Network : JNCCN. 2024 Apr; 22(Apr):140-150. doi: 10.6004/jnccn.2024.0019. pii: .

The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder.

The Journal of urology. 2024 Jul; 212(Jul):11-20. doi: 10.1097/JU.0000000000003985. pii: .

Summary of the 2024 Update of the European Association of Urology Guidelines on Neurourology.

European urology. 2024 Jun; 85(Jun):543-555. doi: 10.1016/j.eururo.2024.03.026. pii: S0302-2838(24)02253-X.

Summary Paper on Underactive Bladder from the European Association of Urology Guidelines on Non-neurogenic Male Lower Urinary Tract Symptoms.

European urology. 2024 Sep; 86(Sep):213-220. doi: 10.1016/j.eururo.2024.04.004. pii: S0302-2838(24)02273-5.

Post-prostatectomy incontinence: a guideline of guidelines.

BJU international. 2024 May; 133(May):513-523. doi: 10.1111/bju.16233. pii: .

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.

European urology. 2024 Aug; 86(Aug):148-163. doi: 10.1016/j.eururo.2024.03.027. pii: S0302-2838(24)02254-1.

2024 Canadian Urological Association guideline: Female stress urinary incontinence.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2024 Apr; 18(Apr):83-102. doi: 10.5489/cuaj.8751. pii: .

European Association of Urology Guidelines on Penile Size Abnormalities and Dysmorphophobia: Summary of the 2023 Guidelines.

European urology focus. 2023 Sep; doi: 10.1016/j.euf.2023.08.012. pii: S2405-4569(23)00197-9.

European Association of Urology Guidelines on the Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 2: Underactive Bladder, Bladder Outlet Obstruction, and Nocturia.

European urology. 2022 Jul; 82(Jul):60-70. doi: 10.1016/j.eururo.2022.01.044. pii: S0302-2838(22)01601-3.

European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence.

European urology. 2022 Jul; 82(Jul):49-59. doi: 10.1016/j.eururo.2022.01.045. pii: S0302-2838(22)01603-7.

Histologic subtypes of urothelial carcinoma: an update.

Current opinion in urology. 2026 Mar; 36(Mar):138-146. doi: 10.1097/MOU.0000000000001358. pii: .

Recent advances in urologic surgical pathology and molecular biomarker testing.

Current opinion in urology. 2026 Mar; 36(Mar):135-137. doi: 10.1097/MOU.0000000000001368. pii: .

Intraoperative assessment of surgical margins during radical prostatectomy: advances and challenges.

Current opinion in urology. 2026 Mar; 36(Mar):180-186. doi: 10.1097/MOU.0000000000001359. pii: .

Testicular germ cell tumors and molecular biomarkers.

Current opinion in urology. 2026 Mar; 36(Mar):205-211. doi: 10.1097/MOU.0000000000001353. pii: .

The role of pathology in immunotherapy and targeted therapy for renal cell carcinoma.

Current opinion in urology. 2026 Mar; 36(Mar):187-195. doi: 10.1097/MOU.0000000000001357. pii: .

Prostate cancer.

Lancet (London, England). 2026 Feb; 407(Feb):622-636. doi: 10.1016/S0140-6736(25)02221-4. pii: S0140-6736(25)02221-4.

A Review of Prostatitis.

JAMA. 2026 Feb; 335(Feb):459. doi: 10.1001/jama.2025.21097. pii: .

Surgical Management of Kidney and Ureteral Stones: AUA Guideline (2026). Part II: Evaluation and Treatment of Patients With Kidney and/or Ureteral Stones.

The Journal of urology. 2026 Feb; 215(Feb):124-131. doi: 10.1097/JU.0000000000004843. pii: .

A rapid evidence assessment for extracorporeal magnetic stimulation to treat urinary incontinence in men.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 2026 Feb; 20(Feb):63-70. doi: 10.5489/cuaj.9320. pii: .

Surgical Management of Kidney and Ureteral Stones: AUA Guideline (2026). Part III: Treatment of Patients With Kidney and/or Ureteral Stones and Future Directions.

The Journal of urology. 2026 Feb; 215(Feb):132-141. doi: 10.1097/JU.0000000000004844. pii: .